ATE240100T1 - Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten - Google Patents

Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten

Info

Publication number
ATE240100T1
ATE240100T1 AT98958077T AT98958077T ATE240100T1 AT E240100 T1 ATE240100 T1 AT E240100T1 AT 98958077 T AT98958077 T AT 98958077T AT 98958077 T AT98958077 T AT 98958077T AT E240100 T1 ATE240100 T1 AT E240100T1
Authority
AT
Austria
Prior art keywords
treatment
angiogenic diseases
cancer
angiogenesis inhibitor
present
Prior art date
Application number
AT98958077T
Other languages
English (en)
Inventor
Roy E Wuthier
Daotai Nie
Original Assignee
Univ South Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ South Carolina filed Critical Univ South Carolina
Application granted granted Critical
Publication of ATE240100T1 publication Critical patent/ATE240100T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98958077T 1997-11-21 1998-11-18 Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten ATE240100T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/975,813 US5932611A (en) 1997-11-21 1997-11-21 Angiogenesis inhibitor for the treatment of cancer
PCT/US1998/024645 WO1999026622A1 (en) 1997-11-21 1998-11-18 Use of fc101 as an angiogenesis inhibitor for the treatment of cancer and other angiogenic diseases

Publications (1)

Publication Number Publication Date
ATE240100T1 true ATE240100T1 (de) 2003-05-15

Family

ID=25523430

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98958077T ATE240100T1 (de) 1997-11-21 1998-11-18 Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten

Country Status (6)

Country Link
US (5) US5932611A (de)
EP (1) EP1049463B1 (de)
AT (1) ATE240100T1 (de)
AU (1) AU749021B2 (de)
DE (1) DE69814691T2 (de)
WO (1) WO1999026622A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932611A (en) * 1997-11-21 1999-08-03 University Of South Carolina Angiogenesis inhibitor for the treatment of cancer
US7361643B2 (en) 2000-02-09 2008-04-22 University Of Puerto Rico Methods for inhibiting angiogenesis
KR100675252B1 (ko) * 2000-03-08 2007-02-08 한국생명공학연구원 신규 7,8-디히드로-잔테논-8-카르복실산 유도체 및 이를생산하는 신규 미생물
US6844705B2 (en) * 2002-12-09 2005-01-18 Intersil Americas Inc. Li-ion/Li-polymer battery charger configured to be DC-powered from multiple types of wall adapters
US7598403B2 (en) 2003-05-16 2009-10-06 The University Of South Carolina Research Foundation Synthesis of chromanones
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US8852925B2 (en) * 2007-12-17 2014-10-07 The Charlotte-Mecklenburg Hospital Authority Bioreactor for cell growth and associated methods
US8344020B2 (en) * 2008-04-11 2013-01-01 University Of South Carolina Use of fusarochromanone and its derivatives in the diagnosis and treatment of cancer and other diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688997A (en) 1994-05-06 1997-11-18 Pharmacopeia, Inc. Process for preparing intermediates for a combinatorial dihydrobenzopyran library
US5932611A (en) * 1997-11-21 1999-08-03 University Of South Carolina Angiogenesis inhibitor for the treatment of cancer

Also Published As

Publication number Publication date
AU1418899A (en) 1999-06-15
AU749021B2 (en) 2002-06-13
US5932611A (en) 1999-08-03
US6660765B2 (en) 2003-12-09
US20010011100A1 (en) 2001-08-02
EP1049463A1 (de) 2000-11-08
WO1999026622A1 (en) 1999-06-03
US20040092580A1 (en) 2004-05-13
US7078433B2 (en) 2006-07-18
DE69814691D1 (de) 2003-06-18
US20030083370A1 (en) 2003-05-01
US6225340B1 (en) 2001-05-01
DE69814691T2 (de) 2003-11-27
EP1049463B1 (de) 2003-05-14

Similar Documents

Publication Publication Date Title
IS4073A (is) Nýtt fjölvirknislyf gegn aukningu mótstöðu
FI972086A7 (fi) Parannetun monilääkeresistenssiaktiivisuuden omaavat uudet aminohappoj ohdokset
TR199901417T2 (xx) Analjezik etkisi olan yeni bile�imler.
IL142066A0 (en) Arylsulfonanilide urea derivatives and pharmaceutical compositions containing the same
BR9810465A (pt) Inibidores da farnesiltransferase de proteìnas
PT1019040E (pt) Inibicao da actividade de p38-quinase por meio de arilureias
PT939627E (pt) Pentafluorobenzenossulfonamidas e analogos
ATE251140T1 (de) N-(2 oxoacetyl oder sulphonyl)- pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität
EP1140840A4 (de) -g(v)-carboxyaryl substituierte diphenyl harnstoffe als raf kinase inhibitoren
ES2181006T3 (es) Uso de amidas de acidos de piridil alcanos, piridil alquenos y/o piridil alquinos en el tratamiento de tumores o en inmunosupresion.
UA40578C2 (uk) Сульфоніламінопіримідини і фармацевтичний препарат на їх основі
DE69830072D1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
IS2114B (is) Kínasólínafleiður til að meðhöndla æxli
EA199900137A1 (ru) Замещенные пиридины в качестве избирательных ингибиторов циклооксигеназы-2
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
TR200101539T2 (tr) Serum glukoz ve trigliserid seviyelerini düşürme yöntemleri.
TR199900048T2 (xx) Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler
DE69535805D1 (de) Neue Carbamate- und Harnstoffderivate als Mittel gegen Multidrugresistenz
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
ATE556705T1 (de) Darreichungsform enthaltend taxol in kristalliner form
EA200200058A1 (ru) Пиримидин-2,4,6-трионовые ингибиторы металлопротеиназ
ATE450265T1 (de) Pharmazeutische mischung zur behandlung von krebs,die dioxolan nukleosidanalogen enthält
BR0007589A (pt) Inibidores da proliferação de células
EA200400689A1 (ru) Фармацевтические и косметические композиции, содержащие ароматические альдегиды, содержащие оксигруппу
BG100930A (bg) Фармацевтични състави и лекарствени средства за профилактика и лечение на ендотелиални нарушения

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties